#LCSM Chat topic 3-Oct-2019: The Path to Research Advocacy
Please join the #LCSM community and moderator Janet Freeman-Daily (@JFreemanDaily) for our next #LCSM Chat on Thursday, October 3, 2019, at 8 pm Eastern Time (5 pm Pacific) to discuss “The Path to Research Advocacy.” Cancer patients and their loved ones who have the skills, interest, and energy may become patient advocates for their disease. Their activities might include providing support and resources to other patients, acting as liaisons between patients and clinicians, raising awareness and educating others about their disease, and engaging in fundraising activities for advocacy and research. Some patient… Read More
#LCSM Chat Topic 03/07: Biomarker Magicians (or, Why We Love Pathologists)
Diagnosing the type of lung cancer from a tissue or liquid biopsy is absolutely critical to selecting treatment and determining the patient’s prognosis. However, for many lung cancer patients and their families, the role of tumor tissue in their diagnosis is a mystery. What happens to tissue collected in a biopsy? How is it analyzed? What is involved in getting helpful answers from biomarker testing? The specialized doctors responsible for answering these questions are pathologists. They identify any lung cancer cells in the biopsied tissue, and guide the patient’s biomarker testing. Unfortunately,… Read More
#LCSM Chat 11/29: What’s a cancer model, and why should I care?
Once your take cancer cells out of a living body, the cancer cells die, right? So how researchers study cancer? One way researchers study cancer is by using “cancer models.” Cancer models are clumps of living cancer cells that exist either in a lab dish (see image above), or in animal models such as mice. Sometimes these models also include other living cells from the host environment. It’s not exactly the same as studying a living cancer in its human host, but it does allow researchers time to study the biology of a cancer… Read More
#LCSM 
You must be logged in to post a comment.